鶹ֱapp

Performance Measures

ACP is working actively in the field of performance measurement because we recognize its importance in the changing health care environment and want to shape its impact on Internal Medicine. The Performance Measurement Committee oversees the College's activities in this area.

The Performance Measurement Committee (PMC) applies criteria to assess the validity of performance measures for healthcare. The criteria are evaluated with a modified RAND-UCLA appropriateness method to determine whether they are evidence-based, methodologically sound, and clinically meaningful.

Latest Performance Measurement Committee Papers

ACP develops clinical policy papers and performance measurement commentaries published in scientific journals to educate ACP members about performance measurement initiatives.

  • (Annals of Internal Medicine, 2023)
  • (Annals of Internal Medicine, 2023)
  • (Annals of Internal Medicine, 2021)
  • (New England Journal of Medicine, 2018)

View all PMC papers

PMC Measure Reviews

This tool has been created to help you filter the reviewed performance measures.

Recent Measure Reviews

Osteoporosis Management in Women who had a Fracture

The percentage of women 50–85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the six months after the fracture.

Date Reviewed: May 4, 2022

Screening for Osteoporosis for Women 65-85 Years of Age

Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis

Date Reviewed: May 4, 2022

Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older

"Percentage of patients aged 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. Note: This measure is submitted by the physician who treats the fracture and who therefore is held accountable for the communication."

Date Reviewed: May 4, 2022

Appropriate Use of DXA Scans in Women Under 65 Years Who do not Meet the Risk Factor Profile for Osteoporosis

Percentage of female patients 50 to 64 years of age without select risk factors for osteoporotic fracture who received an order for a dual-energy x-ray absorptiometry (DXA) scan during the measurement period.

Date Reviewed: May 4, 2022

Screening for Osteoporosis for Men Aged 70 Years and Older

Percentage of male patients aged 70 years and older who had a central dual-energy X-ray absorptiometry (DXA) to screen for osteoporosis

Date Reviewed: May 4, 2022

Vitamin D Level - Effective Control of Low Bone Mass/Osteopenia and Osteoporosis: Therapeutic Level Of 25 OH Vitamin D Level Achieved

Percentage of patients aged 65 years and older diagnosed with osteopenia or osteoporosis whose most recent serum 25 Hydroxy-Vitamin D results is greater than or equal to 30.0 ng/dL

Date Reviewed: May 4, 2022